{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:25:36Z","timestamp":1793827536641,"version":"4.6.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.eururo.2026.06.015","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:33:10Z","timestamp":1783456390000},"page":"491-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Focal Therapy for Localized Prostate Cancer: Maturing Evidence, Evolving Questions"],"prefix":"10.1016","volume":"90","author":[{"given":"Armando","family":"Stabile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2026.06.015_b0005","doi-asserted-by":"crossref","unstructured":"Light A, Peters M, Gopalakrishnan A, Mayor N, Cullen E. Oncological outcomes following focal HIFU and cryotherapy for treatment of nonmetastatic prostate cancer in the United Kingdom: an updated analysis of 3477 patients from the prospective HEAT and ICE registries. Eur Urol 2026;90:479\u201390.","DOI":"10.1016\/j.eururo.2026.05.007"},{"key":"10.1016\/j.eururo.2026.06.015_b0010","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.eururo.2022.01.005","article-title":"Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer: a multi-institute 15-year experience","volume":"81","author":"Reddy","year":"2022","journal-title":"Eur Urol"},{"issue":"87","key":"10.1016\/j.eururo.2026.06.015_b0015","first-page":"157","article-title":"Management of patients with advanced prostate cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)","volume":"2025","author":"Gillessen","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.06.015_b0020","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2024.02.001","article-title":"The transatlantic recommendations for prostate gland evaluation with magnetic resonance imaging after focal therapy (TARGET): a systematic review and international consensus recommendations","volume":"85","author":"Light","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.06.015_b0025","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.eururo.2014.01.001","article-title":"Focal therapy in prostate cancer: international multidisciplinary consensus on trial design","volume":"65","author":"Van Den Bos","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2026.06.015_b0030","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.euo.2025.02.003","article-title":"Outcomes of focal therapy for localized prostate cancer: a systematic review and meta-analysis of prospective studies","volume":"8","author":"\u015alusarczyk","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2026.06.015_b0035","first-page":"1644","article-title":"The PRIMARY score: using intraprostatic (68)Ga-PSMA PET\/CT patterns to optimize prostate cancer diagnosis","volume":"63","author":"Emmett","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.eururo.2026.06.015_b0040","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.eururo.2025.05.006","volume":"88","author":"Mazzone","year":"2025","journal-title":"Eur Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283826022360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283826022360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:44:43Z","timestamp":1793825083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283826022360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0302283826022360"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2026.06.015","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Focal Therapy for Localized Prostate Cancer: Maturing Evidence, Evolving Questions","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2026.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}